Real Life Pediatric Obstructive Sleep Apnea
RELIPOSA
OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN: HEALTH AND NEUROCOGNITIVE IMPACT. Real Life Pediatric Obstructive Sleep Apnea
2 other identifiers
observational
1,200
1 country
2
Brief Summary
OBJECTIVES: PRIMARY: To analyze the cognitive alterations in children with Obstructive Sleep Apnea OSA in different age groups and changes at 12 months after treatment with a protocol based on usual clinical practice. DESIGN: Observational, longitudinal, prospective, and multicenter study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
February 18, 2018
CompletedFirst Posted
Study publicly available on registry
May 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMay 15, 2019
May 1, 2019
3.1 years
February 18, 2018
May 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neurocognitive changes after treatment in children with Obstructive Sleep Apnea (OSA)
Changes from before treatment in neurocognitive score on CUMANIN neuropsychological tests in chilren under 6 years old or ENFEN neuropsychological tests in children over six years old at 1 year after treatment
2018-2021
Secondary Outcomes (2)
Behavior changes after treatment in children with Obstructive Sleep Apnea (OSA)
2018-2021
Sleep changes after treatment in children with Obstructive Sleep Apnea(OSA)
2018-2021
Eligibility Criteria
Children from 3 to 12 years-old referred consecutively to the Sleep Units of the participating sites due to clinical suspicion of OSA.
You may qualify if:
- Children aged 3 to 12 years consecutively referred to the Sleep Units due to clinical suspicion of OSA.
You may not qualify if:
- A significant medical and/or psychiatric comorbidity that may require urgent treatment (Respiratory Failure, Heart Failure, Cardiac Malformations, tumors, psychiatric type disorders that may require specific treatment…)
- Craniofacial malformations, deposit diseases and/or malformation syndromes (including Down's syndrome)
- Already diagnosed neurocognitive type disorders (e.g.: Autism, cerebral palsy, etc.)
- Attention deficit hyperactivity disorders previously diagnosed according to DSM-IV criteria
- Girls ≤ 12 with menarche at the time of starting the study
- Children that refuse to take part in the study (do not sign the Informed Consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Complejo Asistencial Universitario de Burgos
Burgos, 09005, Spain
Hospital Universitario de Burgos
Burgos, 09006, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
María Luz Alonso-Alvarez, MD
Complejo Asistencial Universitario de Burgos
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Medical Doctor
Study Record Dates
First Submitted
February 18, 2018
First Posted
May 15, 2019
Study Start
January 1, 2018
Primary Completion
January 31, 2021
Study Completion
December 31, 2023
Last Updated
May 15, 2019
Record last verified: 2019-05